BiomX Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BiomX Inc. on February 9, 2026, covering events occurring between February 9 and February 13, 2026. The company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol PHGE.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Director Resignations: Jonathan Leff and Jesse Goodman resigned from the Board of Directors effective immediately on February 9, 2026, and February 11, 2026, respectively, for personal reasons. Neither director cited any disagreement with the company regarding operations, policies, or practices.
- Director Appointment: On February 13, 2026, the Board appointed Liat Bidas as a Class II Director to fill one of the vacancies. Her term expires at the 2028 annual meeting of stockholders.
Outlook, Risks, and Management Commentary
The Board determined that Ms. Bidas is qualified and independent under NYSE American rules. She will receive standard director compensation with annual cash fees prorated. An indemnification agreement will be executed on terms consistent with existing director agreements. The company is actively seeking candidates to fill the remaining vacancy on the Board. No specific risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Verify the total number of remaining vacancies on the Board of Directors following the appointment of Ms. Bidas.
- Confirm the specific background and independence status of Liat Bidas as disclosed in the filing.
- Monitor future filings for the appointment of a director to fill the second vacancy left by the resignations.
- Note that this filing contains no financial updates; refer to the most recent 10-K or 10-Q for financial health.